{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:51:06Z","timestamp":1789426266304,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Optic neuritis (ON) in neuromyelitis optica spectrum disorders (NMOSD) regularly leads to more profound vision loss compared to multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein-antibody associated disease (MOGAD). Here we investigate ON-related vision loss in NMOSD compared to MS and MOGAD in order to identify neuroaxonal and retinal contributors to visual dysfunction. In this retrospective study we included patients with aquaporin-4-antibody seropositive NMOSD (n\u2009=\u200928), MOGAD (n\u2009=\u200914), MS (n\u2009=\u200929) and controls (n\u2009=\u200914). We assessed optic nerve damage and fovea morphometry by optical coherence tomography. Visual function was assessed as high (HCVA) and low contrast visual acuity\u00a0(LCVA), and visual fields' mean deviation (MD). In all diseases, lower visual function was associated with peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell and inner plexiform layer (GCIP) thinning following a broken stick model, with pRNFL and GCIP cutoff point at ca. 60\u00a0\u00b5m. HCVA loss per \u00b5m pRNFL and GCIP thinning was stronger in NMOSD compared with MOGAD. Foveal inner rim volume contributed to MD and LCVA in NMOSD eyes, only. Together these data supports that visual dysfunction in NMOSD is associated with neuroaxonal damage beyond the effect seen in MS and MOGAD. A primary retinopathy, respectively M\u00fcller cell pathology, may contribute to this effect.<\/jats:p>","DOI":"10.1038\/s41598-022-19848-4","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:05:59Z","timestamp":1666253159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Structure\u2013function correlates of vision loss in neuromyelitis optica spectrum disorders"],"prefix":"10.1038","volume":"12","author":[{"given":"Norman K.","family":"Gigengack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike C.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedamirhosein","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bereuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankelien","family":"Duchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bellmann-Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schmitz-H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna G.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"19848_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archneurol.2009.107","volume":"66","author":"DS Reich","year":"2009","unstructured":"Reich, D. S. et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch. Neurol. 66, 998\u20131006 (2009).","journal-title":"Arch. Neurol."},{"key":"19848_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius, S., Wildemann, B. & Paul, F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin. Exp. Immunol. 176, 149\u2013164 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"19848_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11910-019-1014-z","volume":"26","author":"DA Tajfirouz","year":"2019","unstructured":"Tajfirouz, D. A., Bhatti, M. T. & Chen, J. J. Clinical characteristics and treatment of MOG-IgG\u2013associated optic neuritis. Curr. Neurol. Neurosci. Rep. 26, 100 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"19848_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.msard.2018.04.006","volume":"22","author":"AU Brandt","year":"2018","unstructured":"Brandt, A. U. et al. Frequent retinal ganglion cell damage after acute optic neuritis. Mult. Scler. Relat. Disord. 22, 141\u2013147 (2018).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"19848_CR5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1177\/1352458519864928","volume":"26","author":"ES Sotirchos","year":"2019","unstructured":"Sotirchos, E. S. et al. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. Mult. Scler. J. 26, 1360\u20131371 (2020).","journal-title":"Mult. Scler. J."},{"key":"19848_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/WNO.0000000000000508","volume":"37","author":"JL Bennett","year":"2017","unstructured":"Bennett, J. L. & Owens, G. P. Neuromyelitis optica: Deciphering a complex immune-mediated astrocytopathy. J. Neuroophthalmol. 37, 291\u2013299 (2017).","journal-title":"J. Neuroophthalmol."},{"key":"19848_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177\u2013189 (2015).","journal-title":"Neurology"},{"key":"19848_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"22","author":"S Jarius","year":"2020","unstructured":"Jarius, S. et al. Neuromyelitis optica. Nat. Rev. Dis. Prim. 22, 85 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"19848_CR9","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1523\/JNEUROSCI.18-07-02506.1998","volume":"18","author":"EA Nagelhus","year":"1998","unstructured":"Nagelhus, E. A. et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: Polarized expression in Muller cells and fibrous astrocytes. J. Neurosci. 18, 2506\u20132519 (1998).","journal-title":"J. Neurosci."},{"key":"19848_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ophtha.2019.01.016","volume":"126","author":"Y You","year":"2019","unstructured":"You, Y. et al. Evidence of M\u00fcller glial dysfunction in patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. Ophthalmology 126, 801\u2013810 (2019).","journal-title":"Ophthalmology"},{"key":"19848_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00415-016-8138-8","volume":"263","author":"IH Jeong","year":"2016","unstructured":"Jeong, I. H., Kim, H. J., Kim, N.-H., Jeong, K. S. & Park, C. Y. Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder. J. Neurol. 263, 1343\u20131348 (2016).","journal-title":"J. Neurol."},{"key":"19848_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000334","volume":"4","author":"FC Oertel","year":"2017","unstructured":"Oertel, F. C. et al. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol. Neuroimmunol. Neuroinflamm. 4, e334 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"19848_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000805","volume":"7","author":"S Motamedi","year":"2020","unstructured":"Motamedi, S. et al.  Altered fovea in AQP4-IgG\u2013seropositive neuromyelitis optica spectrum disorders. Neurol. Neuroimmunol. Neuroinflamm. 7, e805 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"19848_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters, P. et al. Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 87, 1005\u20131015 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19848_CR15","doi-asserted-by":"publisher","first-page":"e718","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl, M. et al. International multicenter examination of MOG antibody assays. Neurol. Neuroimmunol. Neuroinflamm. 7, e718 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"19848_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius, S. et al. MOG encephalomyelitis: International recommendations on diagnosis and antibody testing. J. Neuroinflamm. 15, 134 (2018).","journal-title":"J. Neuroinflamm."},{"key":"19848_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011).","journal-title":"Ann. Neurol."},{"key":"19848_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"19848_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3389\/fneur.2019.01117","volume":"10","author":"S Motamedi","year":"2019","unstructured":"Motamedi, S. et al. Normative data and minimally detectable change for inner retinal layer thicknesses using a semi-automated OCT image segmentation pipeline. Front. Neurol. 10, 1117 (2019).","journal-title":"Front. Neurol."},{"key":"19848_CR20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1364\/BOE.4.001133","volume":"4","author":"A Lang","year":"2013","unstructured":"Lang, A. et al. Retinal layer segmentation of macular OCT images using boundary classification. Biomed. Opt. Express 4, 1133 (2013).","journal-title":"Biomed. Opt. Express"},{"key":"19848_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie, P. et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7, e34823 (2012).","journal-title":"PLoS ONE"},{"key":"19848_CR22","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1364\/BOE.8.004181","volume":"8","author":"SK Yadav","year":"2017","unstructured":"Yadav, S. K. et al. CuBe: parametric modeling of 3D foveal shape using cubic B\u00e9zier. Biomed. Opt. Express 8, 4181\u20134199 (2017).","journal-title":"Biomed. Opt. Express"},{"key":"19848_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","volume":"13","author":"A Aytulun","year":"2021","unstructured":"Aytulun, A. et al. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology\u00a013, 68\u201379 (2021).","journal-title":"Neurology"},{"key":"19848_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. (2014)."},{"key":"19848_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2016)."},{"key":"19848_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"19848_CR27","unstructured":"Barton, K. MuMIn: Multi-model inference. (2019)."},{"key":"19848_CR28","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1167\/iovs.07-0738","volume":"48","author":"H Cheng","year":"2007","unstructured":"Cheng, H., Laron, M., Schiffman, J. S., Tang, R. A. & Frishman, L. J. The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis. Investig. Opthalmol. Vis. Sci. 48, 5798 (2007).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"19848_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"Costello, F. et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann. Neurol. 59, 963\u2013969 (2006).","journal-title":"Ann. Neurol."},{"key":"19848_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00038-012-0363-z","volume":"58","author":"CO Schmidt","year":"2013","unstructured":"Schmidt, C. O., Ittermann, T., Schulz, A., Grabe, H. J. & Baumeister, S. E. Linear, nonlinear or categorical: How to treat complex associations? Splines and nonparametric approaches. Int. J. Public Health 58, 161\u2013165 (2013).","journal-title":"Int. J. Public Health"},{"key":"19848_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1352458520937281","volume":"27","author":"R Deschamps","year":"2021","unstructured":"Deschamps, R. et al. Visual field loss and structure\u2013function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody. Mult. Scler. J. 27, 855\u2013863 (2021).","journal-title":"Mult. Scler. J."},{"key":"19848_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1352458508091367","volume":"14","author":"F Costello","year":"2008","unstructured":"Costello, F. et al. Tracking retinal nerve fiber layer loss after optic neuritis: A prospective study using optical coherence tomography. Mult. Scler. J. 14, 893\u2013905 (2008).","journal-title":"Mult. Scler. J."},{"key":"19848_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10384-018-0607-4","volume":"62","author":"N Mekhasingharak","year":"2018","unstructured":"Mekhasingharak, N. et al. Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis. Jpn. J. Ophthalmol. 62, 598\u2013604 (2018).","journal-title":"Jpn. J. Ophthalmol."},{"key":"19848_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1177\/1352458520977771","volume":"27","author":"AG Filippatou","year":"2021","unstructured":"Filippatou, A. G. et al. Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD. Mult. Scler. J. 27, 1738 (2021).","journal-title":"Mult. Scler. J."},{"key":"19848_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ajo.2014.01.014","volume":"157","author":"T Alasil","year":"2014","unstructured":"Alasil, T. et al. Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: A broken stick model. Am. J. Ophthalmol. 157, 953-959.e2 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"19848_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","volume":"113","author":"JB Fisher","year":"2006","unstructured":"Fisher, J. B. et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113, 324\u2013332 (2006).","journal-title":"Ophthalmology"},{"key":"19848_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00415-020-10097-x","volume":"268","author":"R Vicini","year":"2021","unstructured":"Vicini, R., Br\u00fcgger, D., Abegg, M., Salmen, A. & Grabe, H. M. Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis. J. Neurol. 268, 276\u2013284 (2021).","journal-title":"J. Neurol."},{"key":"19848_CR38","doi-asserted-by":"publisher","first-page":"175628641876208","DOI":"10.1177\/1756286418762083","volume":"11","author":"MS Weber","year":"2018","unstructured":"Weber, M. S., Derfuss, T., Metz, I. & Br\u00fcck, W. Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther. Adv. Neurol. Disord. 11, 175628641876208 (2018).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"19848_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","volume":"25","author":"A Bringmann","year":"2006","unstructured":"Bringmann, A. et al. M\u00fcller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 25, 397\u2013424 (2006).","journal-title":"Prog. Retin. Eye Res."},{"key":"19848_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","volume":"13","author":"CM Felix","year":"2016","unstructured":"Felix, C. M., Levin, M. H. & Verkman, A. S. Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J. Neuroinflammation 13, 275 (2016).","journal-title":"J. Neuroinflamm."},{"key":"19848_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-017-0123-5","volume":"9","author":"FC Oertel","year":"2018","unstructured":"Oertel, F. C., Zimmermann, H., Paul, F. & Brandt, A. U. Optical coherence tomography in neuromyelitis optica spectrum disorders: Potential advantages for individualized monitoring of progression and therapy. EPMA J. 9, 21\u201333 (2018).","journal-title":"EPMA J."},{"issue":"10","key":"19848_CR42","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1007\/s12035-021-02491-x","volume":"58","author":"V Netti","year":"2021","unstructured":"Netti, V. et al. Aquaporin-4 removal from the plasma membrane of human m\u00fcller cells by AQP4-IgG from patients with neuromyelitis optica induces changes in cell volume homeostasis: The first step of retinal injury?. Mol. Neurobiol. 58(10), 5178\u20135193 (2021).","journal-title":"Mol. Neurobiol."},{"key":"19848_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41433-019-0746-y","volume":"34","author":"H Yilmaz","year":"2019","unstructured":"Yilmaz, H., Ersoy, A. & Icel, E. Assessments of vessel density and foveal avascular zone metrics in multiple sclerosis: An optical coherence tomography angiography study. Eye\u00a034, 771\u2013778 (2019).","journal-title":"Eye"},{"key":"19848_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.preteyeres.2013.01.005","volume":"35","author":"JM Provis","year":"2013","unstructured":"Provis, J. M., Dubis, A. M., Maddess, T. & Carroll, J. Adaptation of the central retina for high acuity vision: Cones, the fovea and the avascular zone. Prog. Retin. Eye Res. 35, 63\u201381 (2013).","journal-title":"Prog. Retin. Eye Res."},{"key":"19848_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-019-1521-5","volume":"16","author":"FC Oertel","year":"2019","unstructured":"Oertel, F. C. et al. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: A longitudinal study. J. Neuroinflammation 16, 154 (2019).","journal-title":"J. Neuroinflammation"},{"key":"19848_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2012","unstructured":"Syc, S. B. et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135, 521\u2013533 (2012).","journal-title":"Brain"},{"key":"19848_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","volume":"13","author":"F Pache","year":"2016","unstructured":"Pache, F. et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J. Neuroinflammation 13, 282 (2016).","journal-title":"J. Neuroinflamm."},{"key":"19848_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001068","volume":"8","author":"FC Oertel","year":"2021","unstructured":"Oertel, F. C. et al. Retinal optical coherence tomography in neuromyelitis optica. Neurol. Neuroimmunol. Neuroinflamm. 8, e1068 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"19848_CR49","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1212\/WNL.0000000000008684","volume":"94","author":"M Ringelstein","year":"2020","unstructured":"Ringelstein, M. et al. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Neurology 94, e407\u2013e418 (2020).","journal-title":"Neurology"},{"key":"19848_CR50","doi-asserted-by":"publisher","first-page":"3079141","DOI":"10.1155\/2017\/3079141","volume":"2017","author":"M Zivkovic","year":"2017","unstructured":"Zivkovic, M. et al. Foveal avascular zone in normal tension glaucoma measured by optical coherence tomography angiography. Biomed. Res. Int. 2017, 3079141 (2017).","journal-title":"Biomed. Res. Int."},{"key":"19848_CR51","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.ophtha.2016.07.008","volume":"123","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam, C. et al. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology 123, 2352\u20132367 (2016).","journal-title":"Ophthalmology"},{"key":"19848_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19848-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:12:39Z","timestamp":1666253559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19848-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19848"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19848-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"14 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FO was an employee of Nocturne UG (2018) and recieved research support by American Academy of Neurology (2021\u20132023), National Multiple Sclerosis Society (2021\u20132024) and Deutsche Gesellschaft f\u00fcr Neurologie (2021)\u2014all independent from this project. KR received research support from Novartis Pharma, Merck Serono, German Ministry of Education and Research, European Union (821283-2), Stiftung Charit\u00e9 (BIH Clinical Fellow Program) and Arthur Arnstein Foundation; received travel grants from Guthy Jackson Charitable Foundation.J. Bellmann-Strobl has received speaking honoraria and travel grants from Bayer Healthcare, and sanofi-aventis\/Genzyme, in addition received compensation for serving on a scientific advisory board of Roche, unrelated to the presented work. F. Paul served on the scientific advisory boards of Novartis and MedImmune; received travel funding and\/or speaker honoraria from Bayer, Novartis, Biogen, Teva, Sanofi-Aventis\/Genzyme, Merck Serono, Alexion, Chugai, MedImmune, and Shire; is an associate editor of Neurology: Neuroimmunology & Neuroinflammation; is an academic editor of PLoS ONE; consulted for Sanofi Genzyme, Biogen, MedImmune, Shire, and Alexion; received research support from Bayer, Novartis, Biogen, Teva, Sanofi-Aventis\/Geynzme, Alexion, and Merck Serono; and received research support from the German Research Council, Werth Stiftung of the City of Cologne, German Ministry of Education and Research, Arthur Arnstein Stiftung Berlin, EU FP7 Framework Program, Arthur Arnstein Foundation Berlin, Guthy-Jackson Charitable Foundation, and NMSS. AUB is cofounder and shareholder of medical technology companies Nocturne GmbH and Motognosis GmbH. He is named as inventor on several patent applications describing MS biomarkers, visual perceptive computing based motor function analysis, and retinal image analysis. H.G. Zimmermann received research grants from Novartis and speaking honoraria from Bayer Healthcare and Novartis.The other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17545"}}